Clinical Trials in Detroit

Showing 3581-3600 of 9,449 trials

BIO 300 Non-Small Cell Lung Cancer Study

NCT02567799

The purpose of this study is to determine the safety and effectiveness of BIO 300 Oral Suspension when used in combination with standard dose radiation therapy and chemotherapy in patients with non-small cell lung cancer. Based on preclinical data the investigators hypothesize that BIO 300 Oral Suspension will reduce the incidence of radiation-induced pneumonitis and pulmonary fibrosis.

Carcinoma, Non-Small-Cell Lung

Humanetics Corporation21 participantsStarted Nov 2015

Baltimore, Maryland, United States • Detroit, Michigan, United States • Milwaukee, Wisconsin, United States +1 more locations

WITHDRAWNNA< 1 mile

Incorporating Supersaturated Oxygen in Shock

NCT04876040

A multi-center, prospective randomized (1:1) pilot and feasibility study to evaluate the safety and feasibility of supersaturated oxygen (SSO2) therapy delivered for 60 minutes selectively into the culprit coronary artery of patients presenting with ST elevation myocardial infarction and cardiogenic shock (STEMI-CS) treated using a shock protocol.

Cardiogenic ShockSTEMI

TherOxStarted Dec 2021

Miami, Florida, United States • Springfield, Massachusetts, United States • Detroit, Michigan, United States +4 more locations

BIO 300 Non-Small Cell Lung Cancer Study

Incorporating Supersaturated Oxygen in Shock

Find Trials by Condition in Detroit

Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)

Solyx Single-Incision SlingDynamic Intraoperative Standing Sling Technique (DISST) as an Office-based Procedure

Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

EPI-743 for Mitochondrial Respiratory Chain Diseases

The Metformin Active Surveillance Trial (MAST) Study

Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age

A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Lymphoma

A Study of CFI-400945 Fumarate in Patients With Advanced Cancer

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

A Study of Octave System for Improving Lines and Wrinkles of the Décolleté

A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma

A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis

Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain

Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors